Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

NCT02730169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadotropic Hypogonadism

Interventions

DRUG: BGS649
DRUG: Placebo

Sponsor

Mereo BioPharma